Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Egetis Therapeutics - Filing #690710

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	NOT 12	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	4,137,000,000 SEK	—	—	—	—	—	4,164,000,000 SEK	—	—	—	—	—
Current assets	1,474,000,000 SEK	—	—	—	—	—	1,529,000,000 SEK	—	—	—	—	—
Non-current liabilities	55,000,000 SEK	—	—	—	—	—	31,000,000 SEK	—	—	—	—	—
Current liabilities	494,000,000 SEK	—	—	—	—	—	392,000,000 SEK	—	—	—	—	—
Revenue	—	—	—	226,000,000 SEK	—	—	—	—	—	—	382,000,000 SEK	—
Profit (loss)	—	—	—	1,938,000,000 SEK	—	—	—	—	—	—	1,045,000,000 SEK	—
Other comprehensive income	—	—	—	0 SEK	—	—	—	—	—	—	- SEK	—
Comprehensive income	—	– SEK	– SEK	1,938,000,000 SEK	1,938,000,000 SEK	– SEK	—	– SEK	– SEK	– SEK	1,045,000,000 SEK	1,045,000,000 SEK